Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
CO-PRESENTED BY
LIVE TV DownloadNews18 App
News18 English
272
nda:
Needmore seats to Win
Needmore seats to Win
upa:

Anti-diabetes Drug Also 'Lessens Kidney, Heart Disease' Risk

An anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study published.

AFP Relaxnews

Updated:June 14, 2017, 11:05 AM IST
facebookTwittergoogleskypewhatsapp
Anti-diabetes Drug Also 'Lessens Kidney, Heart Disease' Risk
It found the drug reduced the overall risk of cardiovascular disease by 14 percent and reduced the risk of heart failure hospitalization by 33 percent. (Photo courtesy: AFP Relaxnews/ Savushkin/ Istock.com)
An anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study published on Monday.

The findings, published in the New England Journal of Medicine, came in a clinical trial of more than 10,000 patients in 30 countries, using canagliflozin.

It found the drug reduced the overall risk of cardiovascular disease by 14 percent and reduced the risk of heart failure hospitalization by 33 percent. It was also shown to have a significant impact -- 40 percent less -- on the progression of a serious kidney decline.

The George Institute for Global Health study has major implications for the treatment of type 2 diabetes, which affects around 450 million people worldwide, the authors said.

"Coronary heart disease is the biggest killer by far for people with type 2 diabetes. Our findings suggest not only does canagliflozin significantly reduce the risk of heart disease, it also has many other benefits too," said the group's Bruce Neal.

"We found it also reduced blood pressure and led to weight loss.

"Type 2 diabetes is growing rapidly all over the world and we need drugs that not only deal with glucose levels, but also protect many millions of people from the very real risks of stroke and heart attack."

The study was presented at the American Diabetes Association Conference in San Diego.

The findings were cited as particularly relevant to Australia where around 65 percent of cardiovascular deaths occur in people with diabetes or pre-diabetes, and diabetes is also the leading cause of end-stage kidney disease.

"Both patients and physicians should be tremendously reassured by the results," said co-author Vlado Perkovic, executive director of The George Institute Australia.

"It not only reduces the risk of heart disease, it also provides real protection against kidney decline, which affects many people with diabetes."

However, a significant downside of using the drug was that it doubled the risk of amputation of a toe, foot or leg.

Diabetes can cause a narrowing of blood vessels between the knee and the toes, causing a decrease in oxygen circulation that prevents healing.

Canagliflozin works by blocking the body's reabsorption of sugar or glucose. This results in more glucose being released in urine and a drop in glucose levels. Most other diabetes drugs work by managing insulin levels.

Neal added: "We don't know why there was an increased risk of amputation, and further work is needed in this area."
(Get detailed and live results of each and every seat in the Lok Sabha elections and state Assembly elections in Andhra Pradesh, Odisha, Arunachal Pradesh and Sikkim to know which candidate/party is leading or trailing and to know who has won and who has lost and by what margin. Our one-of-its-kind Election Analytics Centre lets you don a psephologist’s hat and turn into an election expert. Know interesting facts and trivia about the elections and see our informative graphics. Elections = News18)
| Edited by: Manila Venugopal
Read full article
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp
 
 

Live TV

Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results